| P50 | author | Nai-Kong V Cheung | Q88954512 |
| | Brian H Kushner | Q114536202 |
| P2093 | author name string | P C Nowell | |
| | B J Lange | |
| | C A Felix | |
| | E F Rappaport | |
| | M D Megonigal | |
| | T M Williams | |
| | D H Jones | |
| | R B Wilson | |
| | D G Leonard | |
| | K Addya | |
| P2860 | cites work | MSF (MLL septin-like fusion), a fusion partner gene of MLL, in a therapy-related acute myeloid leukemia with a t(11;17)(q23;q25) | Q22009898 |
| | gas7: A gene expressed preferentially in growth-arrested fibroblasts and terminally differentiated Purkinje neurons affects neurite formation | Q24313245 |
| | Leucine-zipper dimerization motif encoded by the AF17 gene fused to ALL-1 (MLL) in acute leukemia | Q24317124 |
| | 'Touchdown' PCR to circumvent spurious priming during gene amplification | Q24630793 |
| | t(11;22)(q23;q11.2) In acute myeloid leukemia of infant twins fuses MLL with hCDCrel, a cell division cycle gene in the genomic region of deletion in DiGeorge and velocardiofacial syndromes | Q24641962 |
| | Panhandle PCR strategy to amplify MLL genomic breakpoints in treatment-related leukemias | Q24654907 |
| | Duplicated regions of AF-4 intron 4 at t(4;11) translocation breakpoints | Q28144573 |
| | The t(4;11) chromosome translocation of human acute leukemias fuses the ALL-1 gene, related to Drosophila trithorax, to the AF-4 gene | Q28201279 |
| | Panhandle polymerase chain reaction amplifies MLL genomic translocation breakpoint involving unknown partner gene | Q28255936 |
| | Secondary leukemia or myelodysplastic syndrome after treatment with epipodophyllotoxins | Q33855281 |
| | Rearrangement of the MLL gene confers a poor prognosis in childhood acute lymphoblastic leukemia, regardless of presenting age. | Q34733137 |
| | Stem cell regulation, tissue ontogeny, and oncogenic events | Q35757499 |
| | Association of CYP3A4 genotype with treatment-related leukemia | Q36643196 |
| | An interstitial 11q23 deletion proven to be a rearrangement interrupting the MLL gene in an infant with acute myeloblastic leukemia. | Q36829667 |
| | Panhandle PCR: a technical advance to amplify MLL genomic translocation breakpoints | Q38336232 |
| | Self-fusion of the ALL1 gene. A new genetic mechanism for acute leukemia | Q40580386 |
| | Highly effective induction therapy for stage 4 neuroblastoma in children over 1 year of age. | Q41663772 |
| | Fine structure of translocation breakpoints in leukemic blasts with chromosomal translocation t(4;11): the DNA damage-repair model of translocation | Q42819800 |
| | Association of germline p53 mutation with MLL segmental jumping translocation in treatment-related leukemia. | Q48004867 |
| | The human MLL gene: nucleotide sequence, homology to the Drosophila trx zinc-finger domain, and alternative splicing | Q48073409 |
| | High risk of leukemia after short-term dose-intensive chemotherapy in young patients with solid tumors. | Q50866450 |
| | Characterization of immunoglobulin and T-cell receptor gene patterns in B-cell precursor acute lymphoblastic leukemia of childhood. | Q51169322 |
| | ALL-1 gene rearrangements in DNA topoisomerase II inhibitor-related leukemia in children. | Q52510288 |
| | Secondary acute myeloid leukemia in children previously treated with alkylating agents, intercalating topoisomerase II inhibitors, and irradiation | Q70457573 |
| | Chromosome band 11q23 translocation breakpoints are DNA topoisomerase II cleavage sites | Q72050036 |
| | Do terminal deletions of 11q23 exist? Identification of undetected translocations with fluorescence in situ hybridization | Q72100930 |
| | Potential role for wild-type p53 in leukemias with MLL gene translocations | Q74452723 |
| | Hematological malignancies with a deletion of 11q23: cytogenetic and clinical aspects. European 11q23 Workshop participants | Q74566325 |
| | Partial tandem duplications of the MLL gene are detectable in peripheral blood and bone marrow of nearly all healthy donors | Q77145850 |
| | Anti-G(D2) antibody treatment of minimal residual stage 4 neuroblastoma diagnosed at more than 1 year of age | Q77302613 |
| | Secondary leukemias induced by topoisomerase-targeted drugs | Q77333785 |
| | Cloning and sequence analysis of four t(9;11) therapy-related leukemia breakpoints | Q77653606 |
| | Neuroblastoma and treatment-related myelodysplasia/leukemia: the Memorial Sloan-Kettering experience and a literature review | Q77669936 |
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | leukemia | Q29496 |
| | chemotherapy | Q974135 |
| P304 | page(s) | 2814-9 | |
| P577 | publication date | 2000-03-14 | |
| P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
| P1476 | title | Detection of leukemia-associated MLL-GAS7 translocation early during chemotherapy with DNA topoisomerase II inhibitors | |
| P478 | volume | 97 | |